14-day Premium Trial Subscription Try For FreeTry Free
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Inogen's (INGN) fourth-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
Inogen Inc. (NASDAQ:INGN ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Cal
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its product sales.
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
Inogen's (INGN) third-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
Inogen, Inc. (NASDAQ:INGN ) Q3 2022 Results Conference Call November 2, 2022 8:00 AM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Cal
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third

Inogen: Little Breathing Room

06:49am, Thursday, 15'th Sep 2022
Inogen has been a long-term growth story which has seen real execution challenges in recent years. Current supply chain woes make up for a tough margin picture, yet operational issues have been seen f
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE